Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 2/2011

01-04-2011 | Original Article

Frequency of prediabetes and influence of various risk factors on the development of prediabetes: a tertiary care hospital experience

Authors: Samiullah Shaikh, Gani Hanif, Kashif, Mona Humera

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2011

Login to get access

Abstract

The objective of study was to determine the frequency of prediabetes and observe the influence of various risk factors on the development of prediabetes at Liaquat University Hospital, Hyderabad. Descriptive case series. Medical outpatient department Liaquat University Hospital, Hyderabad. From 01-03-2007 to 31-03-2008. Total 500 subjects with BMI > 25 and aged either 45 year and above or BMI > 25, with an additional risk factor were enrolled for the study.All diagnosed patients of diabetes were excluded from study. A well designed proforma included demographic information, history regarding first degree relative with diabetes, gestational diabetes, delivery of large baby and related investigations. Fasting blood glucose (FBG) ≥ 100 mg/dl but <126 mg/dl and/or OGTT level ≥140 mg/dl but <200 mg/dl was considered prediabetes. The collected data was analyzed on SPSS version 16.0. This study comprised of 500 subjects of which 306 (61.2%) were male and 194 (38.8%) female. The mean age of the cases were 49.42 ± 7.73 years. Prediabetes was found in 147/500(29.4%) cases of which 109 were female and 38 were male. A strong correlation was found between prediabetes and BMI, persons with h/o diabetes in first degree relative, h/o gestational diabetes, h/o delivery of high birth weight child, HDL <35 mg/dl. Considering the high frequency of prediabetes in the region, provision of vast educational program to prevent the disease is essential and as well screening for prediabetes using FBG and OGTT, especially for obese subjects and those with other risk factors of diabetes.
Literature
1.
go back to reference Alberti G, Zimmet P, Shaw J, et al. Type 2 diabetes in the young: the evolving epidemic: the International Diabetes Federation consensus workshop. Diab Care. 2004;27:1798–811.CrossRef Alberti G, Zimmet P, Shaw J, et al. Type 2 diabetes in the young: the evolving epidemic: the International Diabetes Federation consensus workshop. Diab Care. 2004;27:1798–811.CrossRef
2.
go back to reference Chiasson JL, Brindisi MC, Rabasa-Lhoret R. The prevention of type 2 diabetes: what is the evidence? Minerva Endocrinol. 2005;30:179–91.PubMed Chiasson JL, Brindisi MC, Rabasa-Lhoret R. The prevention of type 2 diabetes: what is the evidence? Minerva Endocrinol. 2005;30:179–91.PubMed
3.
go back to reference Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24:451–63.PubMedCrossRef Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24:451–63.PubMedCrossRef
4.
go back to reference Irons BK, Mazzolini TA, Greene RS. Delaying the onset of type 2 diabetes mellitus in patients with prediabetes. Pharmacotherapy. 2004;24:362–71.PubMedCrossRef Irons BK, Mazzolini TA, Greene RS. Delaying the onset of type 2 diabetes mellitus in patients with prediabetes. Pharmacotherapy. 2004;24:362–71.PubMedCrossRef
5.
go back to reference National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57.
6.
go back to reference American Diabetes Association. Standards of medical care in diabetes—2008. Diab Care. 2008;31 suppl 1:S12–54.CrossRef American Diabetes Association. Standards of medical care in diabetes—2008. Diab Care. 2008;31 suppl 1:S12–54.CrossRef
7.
go back to reference 18th Congress of the International Diabetes Federation. Paris, France, 24–29 August 2003. Diabetologia 2003;46 Suppl. 2:A1–471. 18th Congress of the International Diabetes Federation. Paris, France, 24–29 August 2003. Diabetologia 2003;46 Suppl. 2:A1–471.
8.
go back to reference Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Subclinical states of glucose intolerance and risk of death in the U.S. Diab Care. 2001;24:447–53.CrossRef Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Subclinical states of glucose intolerance and risk of death in the U.S. Diab Care. 2001;24:447–53.CrossRef
9.
go back to reference Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relations hip between glucose and incident cardiovascular events. A meta regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diab Care. 1999;22:233–40.CrossRef Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relations hip between glucose and incident cardiovascular events. A meta regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diab Care. 1999;22:233–40.CrossRef
10.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.PubMedCrossRef
11.
go back to reference Tuomilehto J, Lindstrom J, Eriksson JG, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson JG, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRef
12.
go back to reference Khuwaja AK. Evidence based care of type-2 diabetes mellitus: epidemiology, screening, diagnosis and initial evaluation. J Liaquat Uni Med Health Sci. 2003;2:63–7. Khuwaja AK. Evidence based care of type-2 diabetes mellitus: epidemiology, screening, diagnosis and initial evaluation. J Liaquat Uni Med Health Sci. 2003;2:63–7.
13.
go back to reference Majeed A, Newnham A, Ryan R, Khunti K, Guthrie C. Prevention and cure of type-II diabetes. BMJ. 2002;325:965–6.PubMedCrossRef Majeed A, Newnham A, Ryan R, Khunti K, Guthrie C. Prevention and cure of type-II diabetes. BMJ. 2002;325:965–6.PubMedCrossRef
14.
go back to reference Abdul Ghani MA, Sabbah M, Mauti B, Dakwar N, Kashkosh H, Minuchin O, et al. High frequency of pre-diabetes, undiagnosed diabetes and metabolic syndrome among over weight Arabs in Israel. Isr Med Assoc J. 2005;7:143–7.PubMed Abdul Ghani MA, Sabbah M, Mauti B, Dakwar N, Kashkosh H, Minuchin O, et al. High frequency of pre-diabetes, undiagnosed diabetes and metabolic syndrome among over weight Arabs in Israel. Isr Med Assoc J. 2005;7:143–7.PubMed
15.
go back to reference Benjamin SM, Valdez R, Geiss LS, Rolka BD, Narayan KM. Estimated number of adults with prediabetes in the U.S in 2000: opportunities for prevention. Diab Care. 2003;26:645–9.CrossRef Benjamin SM, Valdez R, Geiss LS, Rolka BD, Narayan KM. Estimated number of adults with prediabetes in the U.S in 2000: opportunities for prevention. Diab Care. 2003;26:645–9.CrossRef
16.
go back to reference Li C, Ford ES, Zhao G, Mokdad AH. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents. Diab Care. 2009;32:342–7.CrossRef Li C, Ford ES, Zhao G, Mokdad AH. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents. Diab Care. 2009;32:342–7.CrossRef
17.
go back to reference Bener A, Zirie M, Al-Rikabi A. Genetics, obesity, and environmental risk factors associated with type-II diabetes. Croat Med J. 2005;46:302–7.PubMed Bener A, Zirie M, Al-Rikabi A. Genetics, obesity, and environmental risk factors associated with type-II diabetes. Croat Med J. 2005;46:302–7.PubMed
18.
go back to reference Yaturu S, Bridges JF, Dhanireddy RR. Preliminary evidence of genetic anticipation in type-II diabetes mellitus. Med Sci Monit. 2005;11:262–5. Yaturu S, Bridges JF, Dhanireddy RR. Preliminary evidence of genetic anticipation in type-II diabetes mellitus. Med Sci Monit. 2005;11:262–5.
19.
go back to reference Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynaecol. 2006;108:1456–62.CrossRef Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynaecol. 2006;108:1456–62.CrossRef
20.
go back to reference Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med 2000;160:898–904. Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med 2000;160:898–904.
21.
go back to reference Virtanen KA, Lozzo P, Hallsten K, Huupponen R, Parkkola R, Janatuinen T. Increased fat mass compensates for insulin resistance in abdominal obesity and type-II diabetes: a positron emitting tomography study. Diabetes. 2005;54:2720–6.PubMedCrossRef Virtanen KA, Lozzo P, Hallsten K, Huupponen R, Parkkola R, Janatuinen T. Increased fat mass compensates for insulin resistance in abdominal obesity and type-II diabetes: a positron emitting tomography study. Diabetes. 2005;54:2720–6.PubMedCrossRef
22.
go back to reference Sadeghi M, Roohafza H, Shirani S, Poormoghadas M, Kelishad R, Baghaii A, et al. Diabetes and associated cardiovascular risk factors in Iran: the Isfahan healthy heart programme. Ann Acad Med Singapore. 2007;36:175–80.PubMed Sadeghi M, Roohafza H, Shirani S, Poormoghadas M, Kelishad R, Baghaii A, et al. Diabetes and associated cardiovascular risk factors in Iran: the Isfahan healthy heart programme. Ann Acad Med Singapore. 2007;36:175–80.PubMed
23.
go back to reference Basit A, Hydrie MZI, Ahmed K, Hakeem R. Prevalence of diabetes, impaired fasting glucose and associated risk factors in a rural area of Baluchistan province according to new ADA criteria. J Pak Med Assoc. 2002;52:351–60. Basit A, Hydrie MZI, Ahmed K, Hakeem R. Prevalence of diabetes, impaired fasting glucose and associated risk factors in a rural area of Baluchistan province according to new ADA criteria. J Pak Med Assoc. 2002;52:351–60.
24.
go back to reference Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among U.S. adults with diabetes, 1988–1994. Am J Prev Med. 2002;22:42–8.PubMedCrossRef Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among U.S. adults with diabetes, 1988–1994. Am J Prev Med. 2002;22:42–8.PubMedCrossRef
25.
go back to reference Bowman L, Armitage J. Diabetes and impaired glucose tolerance: a review of the epidemiological and trial evidence for their role in cardiovascular risk. Semin Vasc Med. 2002;2:383–90.PubMedCrossRef Bowman L, Armitage J. Diabetes and impaired glucose tolerance: a review of the epidemiological and trial evidence for their role in cardiovascular risk. Semin Vasc Med. 2002;2:383–90.PubMedCrossRef
26.
go back to reference International Diabetes Federation IGT/IFG consensus statement. Report of an expert consensus workshop. Diabet Med. 2002;19:708–23.CrossRef International Diabetes Federation IGT/IFG consensus statement. Report of an expert consensus workshop. Diabet Med. 2002;19:708–23.CrossRef
Metadata
Title
Frequency of prediabetes and influence of various risk factors on the development of prediabetes: a tertiary care hospital experience
Authors
Samiullah Shaikh
Gani Hanif
Kashif
Mona Humera
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2011
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-010-0008-9

Other articles of this Issue 2/2011

International Journal of Diabetes in Developing Countries 2/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.